跳至主要内容
临床试验/IRCT20171030037093N14
IRCT20171030037093N14招募中2 期

Comparison of the effect of sodium valproate and Levetiracetam on the prevention of migraine headaches

Shahre-kord University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Age 18 to 65 years old
  • Migraine headache history for at least 6 months before study based on IHS criteria
  • Moderate to severe headache for less than 6 days with Visual Analogue Scale
  • Natural Signs and Natural Nerve Findings.

排除标准

  • Patients with kidney failure, liver disease, heart disease, active stomach ulcer disease or diabetes or abnormal vital symptoms
  • Allergy to valproate and Levetiracetam
  • Pregnant or lactating women
  • Cases of other types of headaches such as sinus headaches
  • Taking nonsteroidal anti-inflammatory drugs within 24 hours or valproate over the past 2 weeks

研究者

发起方
Shahre-kord University of Medical Sciences

相似试验